Repatha

Primary Uses

Repatha is primarily prescribed to help lower low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol. It is used in the following situations:

• Heart Disease Risk Reduction: In adults with established heart disease, it is used to lower the risk of heart attack, stroke, and certain heart surgeries.
• High Cholesterol (Hyperlipidemia): It is used in adults with primary hyperlipidemia to lower LDL cholesterol levels.
• Genetic Conditions: It is used to treat adults with heterozygous familial hypercholesterolemia (HeFH) and both adults and children aged 10 and older with homozygous familial hypercholesterolemia (HoFH), which are inherited conditions that cause extremely high cholesterol levels.

How It Is Used

Repatha is typically used in combination with a low-fat diet. It may be used alone or alongside other cholesterol-lowering medications, such as statins, when those treatments have not lowered cholesterol enough or are not well-tolerated by the patient.

Mechanism of Action

Repatha (evolocumab) belongs to a class of medications known as PCSK9 inhibitors. It is a monoclonal antibody designed to target and block a specific protein in the liver.

How it Lowers Cholesterol

The liver plays a key role in managing cholesterol levels by using special receptors on its surface to capture and remove low-density lipoprotein (LDL), or "bad" cholesterol, from the bloodstream. Under normal conditions, a protein called proprotein convertase subtilisin/kexin type 9 (PCSK9) breaks down these receptors.

Repatha works by:

• Binding to PCSK9: The medication attaches to the PCSK9 protein in the body.
• Protecting Receptors: By blocking PCSK9, Repatha prevents the protein from destroying the liver's LDL receptors.
• Increasing Clearance: With more receptors available on the liver's surface, the body can more efficiently pull LDL cholesterol out of the blood and process it.

This process significantly lowers the amount of LDL cholesterol circulating in the body, which helps reduce the risk of cardiovascular events like heart attacks or strokes in certain patients.

Common Side Effects

Many people using Repatha experience mild side effects. These often include:

• Injection site reactions, such as redness, pain, bruising, or swelling
• Symptoms of the common cold, including sore throat, sneezing, or a runny nose
• Flu or flu-like symptoms
• Back pain
• High blood sugar levels
• Cough
• Urinary tract infection

Serious Side Effects

While rare, serious allergic reactions can occur. Seek emergency medical help if you experience any of the following symptoms:

• Severe rash or hives
• Swelling of the face, lips, tongue, or throat
• Difficulty breathing or swallowing
• Severe dizziness

Allergic Reactions

Serious hypersensitivity reactions, including rash, hives, and swelling of the face or throat (angioedema), have been reported with the use of Repatha. If a serious allergic reaction occurs, treatment should be discontinued and medical assistance sought immediately.

Latex Sensitivity

The needle cover of the single-use prefilled syringe and the autoinjector contains dry natural rubber, which is a derivative of latex. This may cause allergic reactions in individuals with a known sensitivity to latex.

Pregnancy and Breastfeeding

There is limited information regarding the safety of Repatha during pregnancy or while breastfeeding. Healthcare providers should be informed if a patient is pregnant, planning to become pregnant, or nursing to evaluate the potential risks and benefits.

General Precautions

• Storage and Handling: The medication should be stored in the refrigerator and protected from light. It should reach room temperature for at least 30 to 45 minutes before injection and should never be shaken or heated.
• Medical History: Healthcare providers should be aware of any history of liver or kidney disease before treatment begins.
• Monitoring: Blood cholesterol levels are typically monitored to assess how the body is responding to the medication.

Pregnancy

There is limited information regarding the safety of Repatha use during pregnancy. While animal studies have not shown evidence of fetal harm, evolocumab is a monoclonal antibody. These types of proteins are known to cross the placenta, especially during the second and third trimesters. Healthcare providers generally suggest using Repatha during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.

Breastfeeding

It is currently unknown whether Repatha passes into human breast milk or if it has any effect on a nursing infant. Because the safety of this medication during lactation has not been established, individuals should discuss their options with a healthcare professional to weigh the benefits of treatment against potential risks to the baby.

Available Forms

Repatha is a liquid solution provided in single-use delivery systems for subcutaneous injection. These systems include:

• Prefilled Syringe: A single-use syringe for manual administration.
• SureClick Autoinjector: A single-use device that automates the injection process.
• Pushtronex System: An on-body infusor used with a single-use prefilled cartridge to deliver the medication over a set period of time.

Each of these delivery methods is intended for one-time use and should be disposed of in a sharps container after administration.

FDA Approval and Indications

Repatha (evolocumab) is an FDA-approved prescription medication. It belongs to a class of drugs called PCSK9 inhibitors and is used to manage cholesterol levels and reduce cardiovascular risks.

The FDA has approved Repatha for the following indications:

• Cardiovascular Event Prevention: To reduce the risk of heart attack, stroke, and coronary revascularization in adults who have established cardiovascular disease.
• Primary Hyperlipidemia: To lower low-density lipoprotein (LDL) cholesterol in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH).
• Homozygous Familial Hypercholesterolemia (HoFH): To lower LDL cholesterol in adults and pediatric patients aged 10 years and older with HoFH, a rare genetic condition.

Regulatory Status and Safety

Repatha is approved for use as an adjunct to diet, either alone or in combination with other lipid-lowering therapies, such as statins. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for this medication. It is administered as a subcutaneous injection using a prefilled syringe or autoinjector.

Insurance and Coverage

Repatha is a specialty medication, and its cost is largely determined by your health insurance plan. Most plans require prior authorization, a process where your healthcare provider must prove the medication is medically necessary before the insurance company agrees to pay for it.

Financial Assistance

There are several ways patients may reduce the out-of-pocket cost of Repatha:

• Copay Cards: Patients with commercial insurance may be eligible for manufacturer copay cards that lower monthly costs.
• Patient Assistance Programs: For those without insurance or who meet certain financial criteria, programs may offer the drug at a lower cost or for free.
• Medicare: Coverage under Medicare Part D varies by plan, and patients may be responsible for a percentage of the drug's cost during different phases of their coverage.

Because Repatha is a biologic medication, it is typically more expensive than generic statins. Patients are encouraged to check with their insurance provider and pharmacy for the most accurate pricing information.